Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate

Clinical Oral Investigations

Volumn 16, Issue 4, 2012, Pages 1191-1197

  Pietruska, Malgorzata ^a   Pietruski, Jan ^b   Nagy, Katalin ^c   Brecx, Michel ^d   Arweiler, Nicole Birgit ^e   Sculean, Anton ^f  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Dental Practice   (Poland)

^c UNIVERSITY OF SZEGED   (Hungary)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f UNIVERSITY OF BERN   (Switzerland)

Author keywords

Biphasic calcium phosphate; Combination therapy; Controlled clinical study; Enamel matrix derivative; Intrabony defects; Regenerative periodontal therapy

Indexed keywords

CHELATING AGENT; EDETIC ACID; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; HYDROXYAPATITE; HYDROXYAPATITE BETA TRICALCIUM PHOSPHATE; HYDROXYAPATITE-BETA TRICALCIUM PHOSPHATE;

ADULT; ALVEOLAR BONE LOSS; ARTICLE; BONE PROSTHESIS; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GINGIVA DISEASE; GRANULATION TISSUE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PREVENTIVE DENTISTRY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL FLAPS; TOOTH CERVIX; TOOTH PLAQUE; TREATMENT OUTCOME;

ADULT; ALVEOLAR BONE LOSS; BONE SUBSTITUTES; CHELATING AGENTS; CHRONIC PERIODONTITIS; DENTAL ENAMEL PROTEINS; DENTAL PLAQUE INDEX; DENTAL SCALING; EDETIC ACID; FEMALE; FOLLOW-UP STUDIES; GINGIVAL RECESSION; GRANULATION TISSUE; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; HYDROXYAPATITES; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PROSPECTIVE STUDIES; ROOT PLANING; SURGICAL FLAPS; TOOTH CERVIX; TREATMENT OUTCOME;

EID: 84864288642     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-011-0611-2     Document Type: Article

References (42)

1. Wikesjö UME, Selvig KA (1999) Periodontal wound healing and regeneration. Periodontol 2000 19: 21-39.
2. Hammarström L, Heijl L, Gestrelius S (1997) Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 24: 669-677.
3. Sculean A, Donos N, Brecx M, Reich E, Karring T (2000) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. An experimental study in monkeys. J Clin Periodontol 27: 466-472.
4. Gkranias ND, Graziani F, Sculean A, Donos N (2010) Wound healing following regenerative procedures in furcation degree III defects: histomorphometric outcomes. Clin Oral Investig. Oct 22 (in press).
5. Heijl L (1997) Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 24: 693-696.
6. Sculean A, Donos N, Windisch P, Gera I, Brecx M, Reich E, Karring T (1999) Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 34: 310-322.
7. Sculean A, Chiantella GC, Windisch P, Donos N (2000) Clinical and histologic evaluation of treatment of intrabony defects with an enamel matrix protein derivative (Emdogain®). Int J Periodontics Restorative Dent 20: 375-381.
8. Yukna RA, Mellonig J (2000) Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 71: 752-759.
9. Sculean A, Stavropoulos A, Berakdar M, Windisch P, Karring T, Brecx M (2005) Formation of human cementum following different modalities of regenerative therapy. Clin Oral Investig 9: 58-64.
10. Bosshardt DD, Sculean A, Windisch P, Pietursson BE, Lang NP (2005) Effects of enamel matrix proteins on tissue formation along the roots of human teeth. J Periodontal Res 40: 158-167.
11. Mazjoub Z, Bobbo M, Atiyeh F, Cordioli G (2005) Two patterns of histologic healing in an intrabony defect following treatment with an enamel matrix derivative: a human case report. Int J Periodontics Restorative Dent 25: 283-294.
12. Heijl L, Heden G, Svardström G, Östgren A (1997) Enamel matrix derivative (Emdogain®) in the treatment of intrabony periodontal defects. J Clin Periodontol 24: 705-714.
13. Pontoriero R, Wennström J, Lindhe J (1999) The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 26: 833-840.
14. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D (2001) A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study. J Periodontol 72: 25-34.
15. Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E (2001) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 28: 397-403.
16. Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, Silvestri M, Tiedemann C, Topoll H, Vangsted T, Wallkamm B (2002) Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicentre randomized controlled clinical trial. J Clin Periodontol 29: 317-325.
17. Guida L, Annunziata M, Belardo S, Farina R, Scabbia A, Trombelli L (2007) Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. J Periodontol 78: 231-238.
18. Gurinsky BS, Mills MP, Mellonig JT (2004) Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans. J Periodontol 75: 1309-1318.
19. Aspriello SD, Ferrante L, Rubini C, Piemontese M (2011) Comparative study of DFDBA in combination with enamel matrix derivative versus DFDBA alone for treatment of periodontal intrabony defects at 12 months post-surgery. Clin Oral Invest 15: 225-232.
20. Yamamoto S, Masuda H, Shibukawa Y, Yamada S (2007) Combination of bovine-derived xenografts and enamel matrix derivative in the treatment of intrabony periodontal defects in dogs. Int J Periodontics Restorative Dent 27: 471-479.
21. Sculean A, Windisch P, Keglevich T, Chiantella GC, Gera I, Donos N (2003) Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine-derived xenograft. Int J Periodontics Restorative Dent 23: 47-55.
22. Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB (2000) A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol 71: 1110-1116.
23. Velasquez-Plata D, Scheyer ET, Mellonig JT (2002) Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol 73: 433-440.
24. Zucchelli G, Amore C, Montebugnoli L, De Sanctis M (2003) Enamel matrix proteins and bovine porous mineral in the treatment of intrabony defects: a comparative controlled clinical trial. J Periodontol 74: 1725-1735.
25. Kuru B, Yilmaz S, Argin K, Noyan U (2006) Enamel matrix derivative alone or in combination with a bioactive glass in wide intrabony defects. Clin Oral Invest 10: 227-234.
26. Sculean A, Pietruska M, Arweiler NB, Auschill TM, Nemcovsky C (2007) Four year results of a prospective controlled clinical study evaluating healing of intrabony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass. J Clin Periodontol 34: 507-513.
27. Bokan I, Bill JS, Schlagenhauf U (2006) Primary flap closure combined with Emdogain® alone or Emdogain® and Cerasorb® in the treatment of intra-bony defects. J Clin Periodontol 33: 885-893.
28. Nery EB, LeGeros RZ, Lynch KL, Lee K (1992) Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/βTCP in periodontal osseous defects. J Periodontol 63: 729-735.
29. Jensen SS, Yeo A, Dard M, Hunziker E, Schenk R, Buser D (2007) Evaluation of a novel biphasic calcium phosphate in standardized bone defects. A histologic and histomorphometric study in the mandibles of minipigs. Clin Oral Implants Res 18: 752-760.
30. Stein JM, Fickl S, Yekta SS, Hoischen U, Ocklenburg C, Smeets R (2009) Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial. J Periodontol 80: 1774-1782.
31. Jepsen S, Topoll H, Rengers H, Heinz B, Teich M, Hoffmann T, Al-Machot E, Meyle J, Jervøe-Storm PM (2008) Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: a multicentre randomized controlled clinical trial. J Clin Periodontol 35: 420-428.
32. Meyle J, Hoffmann T, Topoll H, Heinz B, Al-Machot E, Jervøe-Storm P-M, Meiß C, Eickholz P, Jepsen S (2011) A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months. J Clin Periodontol 38: 652-660.
33. Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4: 1-6.
34. Löe H (1967) The gingival index, the plaque index and the retention index systems. J Periodontol 38: 610-616.
35. Blomlöf JPS, Blomlöf LB, Lindskog SF (1996) Smear removal and collagen exposure after non-surgical root planing followed by etching with EDTA gel preparation. J Periodontol 67: 841-845.
36. Gunsolley JC, Elswick RK, Davenport JM (1998) Equivalence and superiority testing in regeneration clinical trials. J Periodontol 69: 521-527.
37. Kahldahl WB, Kalkwarf KL, Patil KD, Molvar MP, Dyer JK (1996) Long-term evalution of periodontal therapy: I. Respone to 4 therapeutic modalities. J Periodontol 67: 93-102.
38. Tonetti MS, Pini Prato G, Cortellini P (1996) Factors affecting the healing response of intrabony defects following guided tissue regeneration and access flap surgery. J Clin Periodontol 23: 548-556.
39. Sculean A, Nikolidakis D, Schwarz F (2008) Regeneration of periodontal tissues: combinations of barrier membranes and grafting materials-biological foundation and preclinical evidence. A systematic review. J Clin Periodontol 35(suppl 8): 106-116.
40. Iorio-Siciliano V, Andreuccetti G, Siciliano AI, Blasi A, Sculean A, Salvi GE (2011) Clinical outcome following treatment of non-contained intrabony defects with enamel matrix derivative (EMD) or guided tissue regeneration (GTR). A 12-month randomized controlled clinical trial. J Periodontol 82: 62-71.
41. Tonetti MS, Pini-Prato G, Cortellini P (1995) Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol 22: 229-234.
42. Sculean A, Windisch P, Szendröi-Kiss D, Horváth A, Rosta P, Becker J, Gera I, Schwarz F (2008) Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects. J Periodontol 79: 1991-1999.